[Market Feature] P&S Robotics, a Hidden Humanoid Technology Stock... Strength Lies in Profitability

P&S Robotics is showing strong performance. As the corporate value of companies related to humanoid robots surges, interest in P&S Robotics is also increasing. The core technology secured by P&S Robotics is a platform-based technology that can be expanded not only to lower limb gait rehabilitation robots but also to upper limb rehabilitation robots, wearable robots, and humanoid robots. This is based on robot design, software, and electronic control technology, all developed entirely with in-house technology.

The company’s differentiated technologies, which were not developed in existing rehabilitation robot systems, have been validated through multiple clinical trials. These are proprietary technologies of P&S Robotics, registered for patents both in Korea and overseas. The Walkbot gait rehabilitation robot system is an advanced system that can provide the most complete human-like gait training for patients with various conditions and body types.

As of 11:17 a.m. on December 12, 2025, P&S Robotics was trading at 13,220 won, up 1,110 won (9.17%) from the previous trading day.

Since its founding, P&S Robotics has developed more than 300 core robotic technologies, including humanoid robots, multi-joint robots, haptic devices, and robot joint reducers. By strengthening its medical device quality management and global sales service capabilities, the company introduced the exoskeleton gait rehabilitation robot "Walkbot" in 2011. With a shipping price of 300 million to 400 million won, about 20 units of Walkbot are produced annually. The company plans to increase production to 60 units per year within this year.

Kim Hakjun, a researcher at Kiwoom Securities, stated, "The gait rehabilitation market has a high technological entry barrier compared to the overall market size, making it difficult for new competitors to enter. As export references accumulate and the company is one of the major players domestically, both market growth and performance growth are expected."

He added, "An AI-based, patient-customized shoulder training robot named HealerBot is also in preparation. Although it has not yet been released, it was exhibited at the medical exhibition 'MEDICA.'"

Kim also explained, "The strength of P&S Robotics lies in its steady profitability. If topline expansion occurs in the future, an operating leverage effect can also be expected."

He analyzed, "The number of employees, which was around 20 at the time of the company's listing in July last year, increased to about 50 as of the end of the third quarter this year. The company is continuing to invest in proactive workforce expansion for future growth."

Yoon Cheolhwan, a researcher at Korea Investment & Securities, said, "Recently, a 'replacement demand market' is forming in the rehabilitation robot sector due to the aging of existing products. Competitors are currently experiencing financial and operational issues."

He added, "P&S Robotics is expected to benefit as a result. The rehabilitation robot market is projected to grow at an average annual rate of 27.2%." He further emphasized, "P&S Robotics is expected to fully benefit from this, based on its solid financial position and high contribution margin."